Abstract:Abstract: Objective: This study investigates the mechanism of acupuncture stimulation of myofascial trigger points in the treatment of Myofascial Pain Syndrome (MPS) Based on the BDNF TrkB p38/JNK signaling pathway. Method: Establishing an MPS rat model using a combination of percussion and centrifugal exercise, after intervention with electroacupuncture stimulation of pain points and oral administration of celecoxib, preparing electroacupuncture rat serum. Lipopolysaccharide (LPS) induced BV-2 cell inflammatory state in MPS, and intervene with electroacupuncture rat serum, celecoxib containing serum, and BDNF inhibitor (K-252a), respectively. At the same time, SD rats were divided into normal group, model group, electroacupuncture group, and Western medicine group. The replication method of MPS rat model and intervene method is the same as above. After the experiment, the morphology of each group of cells was observed under an inverted microscope, the activity of each group of cells was detected by CCK8 method, and the level of IL-1β, IL-6, TNF-α, IL-10 in cell supernatant of each group as detected by Elisa. The average optical density and average fluorescence intensity in OX-42 of the cells in each group were detected by immunocytochemistry and immunofluorescence. Masson staining was used to observe the morphology of muscle tissue in each group of rats. RT-PCR was used to detect the expression levels of BDNF, TrkB, P38, and JNK mRNA in each group of cells and muscle tissue. Wes was used to detect the protein levels of BDNF, TrkB, p-TrkB, p38, p-P38, JNK, and p-JNK in each group of cells and muscle tissue. Result: In vitro experiments showed that all intervention methods could reduce the level of IL-1β, IL-6, TNF-α and increase the level of IL-10, while reducing cell activation and apoptosis levels; Electroacupuncture and Western medicine intervention can reduce the mRNA expression levels of BDNF, TrkB, P38, and JNK in each group of BV-2 cells and muscle tissue, as well as the protein expression levels of BDNF, TrkB, p-TrkB, p38, p-P38, JNK, and p-JNK, in order to reduce central sensitization and then treat MPS. In vitro experiments showed that the BDNF inhibitor and Western medicine group performed better than the electroacupuncture group, while in vivo experiments showed that the electroacupuncture group performed better than the Western medicine group. Conclusion: The experimental results in vitro and in vivo confirm that acupuncture stimulation can treat MPS by reducing central sensitization, and the specific mechanism is related to the inhibition the BDNF TrkB p38/JNK signaling pathway.